Visit COVID-19 resources

[Skip to Content]

macular oedema

Statement in response to NICE announcing their positive final guidance for Eylea® for the treatment of macular oedema secondary to CRVO

Dec 30
2014

Statement from The Royal College of Ophthalmologists in response to NICE announcing their positive final guidance for Eylea® for the treatment of macular oedema secondary to CRVO February 2014

  • 30 December 2014

Interim Guidelines for Management of Retinal Vein Occlusion 2010

Dec 30
2014

In view of the significant ophthalmological and medical consequences of retinal vein occlusion, these guidelines promote a good standard of practice and the achievement of best visual and medical outcome.

  • 30 December 2014